New insights into HIV latent cells yield potential cure targets
Making Purdue Pharma pay isn’t enough on its own to fix the pharmaceutical industry’s deeper problems
27 July 2022Botswana hits ‘historic’ UN goal against HIV: report
27 July 2022New insights into HIV latent cells yield potential cure targets
In a presentation today at AIDS 2022, the 24th International AIDS Conference in Montreal, scientists with the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC) and their collaborators described how their use of cutting-edge technology revealed new insights into cellular reservoirs of HIV and what those observations could mean for the next steps in HIV cure research. NIAID is part of the National Institutes of Health.
